95 related articles for article (PubMed ID: 7476898)
1. Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor.
Chung FZ; Wu LH; Tian Y; Vartanian MA; Lee H; Bikker J; Humblet C; Pritchard MC; Raphy J; Suman-Chauhan N
Mol Pharmacol; 1995 Oct; 48(4):711-6. PubMed ID: 7476898
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of [125I][MePhe7]neurokinin B binding to tachykinin NK3 receptors: evidence for interspecies variance.
Suman-Chauhan N; Grimson P; Guard S; Madden Z; Chung FZ; Watling K; Pinnock R; Woodruff G
Eur J Pharmacol; 1994 Sep; 269(1):65-72. PubMed ID: 7530207
[TBL] [Abstract][Full Text] [Related]
3. Characterization of NK3 receptors in rabbit isolated iris sphincter muscle.
Medhurst AD; Parsons AA; Roberts JC; Hay DW
Br J Pharmacol; 1997 Jan; 120(1):93-101. PubMed ID: 9117105
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells.
Oury-Donat F; Carayon P; Thurneyssen O; Pailhon V; Emonds-Alt X; Soubrié P; Le Fur G
J Pharmacol Exp Ther; 1995 Jul; 274(1):148-54. PubMed ID: 7616392
[TBL] [Abstract][Full Text] [Related]
5. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
Beaujouan JC; Saffroy M; Torrens Y; Glowinski J
Eur J Pharmacol; 1997 Jan; 319(2-3):307-16. PubMed ID: 9042606
[TBL] [Abstract][Full Text] [Related]
6. The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors.
Chung FZ; Wu LH; Vartanian MA; Watling KJ; Guard S; Woodruff GN; Oxender DL
Biochem Biophys Res Commun; 1994 Feb; 198(3):967-72. PubMed ID: 8117304
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
8. Neurokinin-3 receptor-specific antagonists talnetant and osanetant show distinct mode of action in cellular Ca2+ mobilization but display similar binding kinetics and identical mechanism of binding in ligand cross-competition.
Tian G; Wilkins D; Scott CW
Mol Pharmacol; 2007 Mar; 71(3):902-11. PubMed ID: 17172464
[TBL] [Abstract][Full Text] [Related]
9. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor.
Emonds-Alt X; Bichon D; Ducoux JP; Heaulme M; Miloux B; Poncelet M; Proietto V; Van Broeck D; Vilain P; Neliat G
Life Sci; 1995; 56(1):PL27-32. PubMed ID: 7830490
[TBL] [Abstract][Full Text] [Related]
10. Identification of methionine134 and alanine146 in the second transmembrane segment of the human tachykinin NK3 receptor as reduces involved in species-selective binding to SR 48968.
Wu LH; Vartanian MA; Oxender DL; Chung FZ
Biochem Biophys Res Commun; 1994 Feb; 198(3):961-6. PubMed ID: 8117303
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist.
Emonds-Alt X; Proietto V; Steinberg R; Advenier C; Daoui S; Naline E; Gueudet C; Michaud JC; Oury-Donat F; Poncelet M; Vilain P; Le Fur G; Maffrand JP; Soubrié P; Pascal M
Can J Physiol Pharmacol; 2002 May; 80(5):482-8. PubMed ID: 12056557
[TBL] [Abstract][Full Text] [Related]
12. Characterization of tachykinin mediated increases in [Ca2+]i in Chinese hamster ovary cells expressing human tachykinin NK3 receptors.
Pinnock RD; Suman-Chauhan N; Chung FZ; Webdale L; Madden Z; Hill DR; Woodruff GN
Eur J Pharmacol; 1994 Sep; 269(1):73-8. PubMed ID: 7530208
[TBL] [Abstract][Full Text] [Related]
13. Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscle.
Medhurst AD; Hirst WD; Jerman JC; Meakin J; Roberts JC; Testa T; Smart D
Br J Pharmacol; 1999 Oct; 128(3):627-36. PubMed ID: 10516642
[TBL] [Abstract][Full Text] [Related]
14. Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists.
Krause JE; Staveteig PT; Mentzer JN; Schmidt SK; Tucker JB; Brodbeck RM; Bu JY; Karpitskiy VV
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):310-5. PubMed ID: 8990205
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Meini S; Catalani C; Bellucci F; Cucchi P; Giuliani S; Zappitelli S; Rotondaro L; Pasqui F; Guidi A; Altamura M; Giolitti A; Maggi CA
Eur J Pharmacol; 2005 Jun; 516(2):104-11. PubMed ID: 15925360
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
17. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
18. Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists.
Boden P; Eden JM; Hodgson J; Horwell DC; Hughes J; McKnight AT; Lewthwaite RA; Pritchard MC; Raphy J; Meecham K; Ratcliffe GS; Suman-Chauhan N; Woodruff GN
J Med Chem; 1996 Apr; 39(8):1664-75. PubMed ID: 8648606
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the binding of [125I-iodo-histidyl, methyl-Phe7] neurokinin B to the neurokinin-3 receptor.
Sadowski S; Huang RR; Fong TM; Marko O; Cascieri MA
Neuropeptides; 1993 Jun; 24(6):317-9. PubMed ID: 7688872
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
